Navigation Links
Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
Date:6/18/2008

WINSTON-SALEM, N.C., June 18 /PRNewswire/ -- Pilot Therapeutics Holdings, Inc. today announced the relaunch of Pilot Therapeutics as Gene Smart(TM) Health.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080618/CLW006LOGO )

As an innovator in gene-based nutrition, Gene Smart(TM) Health uniquely combines breakthrough scientific innovation and an in-depth understanding of the health, food, nutrition, and wellness markets to create major new businesses that empower individuals to take care of their health and live life abundantly.

"Through the scientific leadership of our Founder and Chief Science Officer, Dr. Floyd 'Ski' Chilton, we are at the forefront in understanding relationships between nutrition, gene expression, inflammation and health," said Ross Consaul, CEO of Gene Smart(TM) Health.

The company is developing three distinct businesses: Gene Smart(TM) Therapeutics, Gene Smart(TM) Ingredients, and Gene Smart(TM) Wellness.

"Our world's health crisis, with unprecedented levels of obesity accompanied by dramatic increases in chronic inflammatory conditions, is a bold call for action for science-based innovations in prevention, nutrition and wellness," said Keith Wakeman, President of Gene Smart(TM) Health. "Revolutionary advances in our understanding of both nutrition and the human genome provide us with new tools to begin to address these enormous problems."

Gene Smart(TM) Therapeutics is developing a pipeline of over the counter (OTC) products, functional foods & beverages, and veterinary medical foods to prevent and treat chronic inflammatory conditions; Gene Smart(TM) Ingredients creates science-based nutrition ingredients to improve the healthfulness of the world's food supply; and Gene Smart(TM) Wellness integrates prevention into healthcare through clinically validated wellness programs.

"This relaunch is an important mile
'/>"/>

SOURCE Gene Smart Health
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
2. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
3. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
4. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
5. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, for ... surveyed U.S. and European rheumatologists cite a therapy,s ... that most influences their prescribing decisions. Over 60 ... rheumatologists, respectively, rank the percentage of patients achieving ...
(Date:6/19/2013)... , June 19, 2013 BD Biosciences, a ... BDX ), a leading global medical technology company, today announced ... , the latest in its line of high-performance research flow ... delivers high-performance multicolor analysis with the most compact footprint in ... cm) and a height of 30" (76.2 cm). Recognizing that ...
(Date:6/19/2013)... 19, 2013 /PRNewswire-iReach/ -- In its first ... pharmaceutical company dedicated to advancing development of ... sustained release drug therapies in patient disease ... announced the acquisition of Enzon Pharmaceutical,s PEGylation ... associated product pipeline. Acquisition of this technology ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
...   SAP America Inc., a subsidiary of ... SAP ), today introduced the SAP® Collaborative E-Care Management application ... the application aims to connect care providers, patients and their ... at HIMSS 2012 , being held February 20–24 in ...
... SurgLine International, Inc. (SGLN.PK). Thomas Toland, ... the past six months we have made certain public ... contracts and a pending acquisition in an effort to ... Our management team has completed an internal ...
Cached Medicine Technology:Newsbyte: SAP to Integrate Healthcare in the Community Through Collaborative Care 2SurgLine International, Inc. Update to Shareholders on Revenue Pipeline and Organizational Changes 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 DiscountFurnaceFilter.com, the number ... to offer the 5-2-1 Compressor Saver kit at an exceptional ... Start Kit) aids the air conditioning unit during start up, ... prevent air compressor or unit burn out. , The ... so the air conditioner uses less power to start and ...
(Date:6/19/2013)... Alternatives, a revolutionary new treatment facility ... using drugs while allowing them to continue drinking alcohol. ... Alternatives, believe that abstinence-only approaches force people to wait ... that this approach hurts instead of helping. It ... States need treatment for addiction but only 3 million ...
(Date:6/19/2013)... Kansas City, MO (PRWEB) June 19, 2013 Kansas ... as part of Main Street Day . A section of ... and pedestrian traffic during the afternoon of the event. The ... to host the event, which will help Kansas City join the ... have used Ciclovia as a tool to foster community vibrancy and ...
(Date:6/19/2013)... Many trying-to-conceive couples seek medical intervention ... to a recent study published in ... of this research confirm what Fairhaven Health has ... that trying-to-conceive women would benefit from tracking ovulation, ... Fairhaven Health is a leading provider of ovulation ...
(Date:6/19/2013)... 19, 2013 In 2011, the value ... 710 million. Generic drugs form the largest sector, accounting ... The pharmaceutical industry is a significant contributor to the ... country’s GDP. Approximately 50% of the total domestic chemical ... industry. Hemofarm, Galenika and Zdravlje Actavis are key participants ...
Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2
... bird, Paris Hilton, is reportedly having a tough time with ... video, One Night In Paris , with ex- beau Rick ... at the Lynwood centre by saying 'Paris sure knows how ... ,A jail inmate, Danita Daniel, said that prisoners were constantly ...
... about racial inequalities, even at the cost of lives, are ... finds that blacks are far less likely than whites ... heart attack, which leave them more vulnerable to future fatal ... Journal of the American Medical Association, tracked 1.2 million Medicare ...
... the prosthesis that has helped thousands of disabled worldwide to ... first centre on foreign soil . ,The Colombian government ... of the artificial limb, to set up base in the ... with a Colombia-based NGO. ,M.K. Mathur of BMVSS ...
... new study, skin cancer levels have shown a significant increase ... is more likely to affect those living in more affluent ... people are more prone to the disease. ,Researchers, ... over a 12-year period, reported a 20 per cent increase ...
... informed by my physician that what I "thought" to be a ... me without antibiotics I could wind up in the hospital . ... can afford to "die" because I have life insurance, only I ... "abuse" is. It is the over inflated prices of medical care ...
... new study has emphasised the safety and efficacy of ... (RA) patients . ,Biologics, such as etanercept, ... protein in the body called tumour necrosis factor that ... etanercept, also known as an anti-TNF therapy, etanercept has ...
Cached Medicine News:Health News:Racial Discrimination Takes The Nobility Out Of Doctoring 2Health News:Jaipur Foot All Set to Launch Its Centre in Columbia 2Health News:Deadly Skin Cancer Bites the Rich Harder 2Health News:Deadly Skin Cancer Bites the Rich Harder 3Health News:Ask Right Questions and Save Country from Further Healthcare Crisis: Michael Moore 2Health News:Study Reinforces Safety of Long-term Biologic Treatment for Rheumatoid Arthritis 2
FlexStationII offers the highest level of flexibility in developing functional cellular assays and analyzing real time kinetic data....
... C&L Dye Fluorometer utilizes unique microprocessor-controlled filter ... and detection optics. The filter wheels can ... numerous types of applications. With this fluorometer, ... measuring one or two wavelengths. The C&L ...
... is a multifunctional single ... give you utmost flexibility ... and absorbance. Modulus operates ... dedicated luminometer, or a ...
The VICTOR² D fluorometer is suitable for clinical assays based on fluorescence or time-resolved fluorescence from a wide variety of plates....
Medicine Products: